These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23462024)
1. Anticipating and managing opioid side effects in the elderly. Martin CM; Forrester CS Consult Pharm; 2013 Mar; 28(3):150-9. PubMed ID: 23462024 [TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal events after opioid treatment in nonmalignant pain: correlates of occurrence and impact on health-related quality of life. Lapane KL; Quilliam BJ; Benson C; Chow W; Kim MS J Opioid Manag; 2013; 9(3):205-16. PubMed ID: 23771570 [TBL] [Abstract][Full Text] [Related]
4. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y; Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893 [TBL] [Abstract][Full Text] [Related]
5. Balancing opioid-induced gastrointestinal side effects with pain management: Insights from the online community. Whitman CB; Reid MW; Arnold C; Patel H; Ursos L; Sa'adon R; Pourmorady J; Spiegel BM J Opioid Manag; 2015; 11(5):383-91. PubMed ID: 26535966 [TBL] [Abstract][Full Text] [Related]
6. Side effects of opioids during short-term administration: effect of age, gender, and race. Cepeda MS; Farrar JT; Baumgarten M; Boston R; Carr DB; Strom BL Clin Pharmacol Ther; 2003 Aug; 74(2):102-12. PubMed ID: 12891220 [TBL] [Abstract][Full Text] [Related]
8. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 22356224 [TBL] [Abstract][Full Text] [Related]
9. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Porreca F; Ossipov MH Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436 [TBL] [Abstract][Full Text] [Related]
10. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Kwong WJ; Diels J; Kavanagh S Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473 [TBL] [Abstract][Full Text] [Related]
11. Management of expected and unexpected opioid-related side effects. Harris JD Clin J Pain; 2008 May; 24 Suppl 10():S8-S13. PubMed ID: 18418226 [TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159 [TBL] [Abstract][Full Text] [Related]
13. Palliative care and pain: new strategies for managing opioid bowel dysfunction. Thomas JR; Cooney GA; Slatkin NE J Palliat Med; 2008 Sep; 11 Suppl 1():S1-19; quiz S21-2. PubMed ID: 18800914 [TBL] [Abstract][Full Text] [Related]
14. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Candiotti KA; Gitlin MC Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361 [TBL] [Abstract][Full Text] [Related]
15. Current management of opioid-related side effects. O'Mahony S; Coyle N; Payne R Oncology (Williston Park); 2001 Jan; 15(1):61-73, 77; discussion 77-8, 80-2. PubMed ID: 11271983 [TBL] [Abstract][Full Text] [Related]
16. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Imam MZ; Kuo A; Ghassabian S; Smith MT Neuropharmacology; 2018 Mar; 131():238-255. PubMed ID: 29273520 [TBL] [Abstract][Full Text] [Related]